Under the HRSA program, enacted by Congress in 2005, the CIBMTR will collect and maintain a standardized database of allogeneic (related and unrelated donor) marrow and cord blood transplants performed in the United States. The program requires that all U.S. transplant centers performing allogeneic transplants provide patient outcomes data to this new national Stem Cell Therapeutic Outcomes Database.